NOVARTIS PHARMACEUTICALS CORPORATION

ILARIS has been associated with an increased risk of serious infections. Exercise caution when administering ILARIS to patients with infections, a history of recurring infections or underlying conditions, which may predispose them to infections. Avoid administering ILARIS to patients during an active infection requiring medical intervention. Discontinue ILARIS if a patient develops a serious infection... Discover information and resources to help HCPs identify autoinflammatory diseases like Gout Flares, SJIA, AOSD, and PFS. See full Prescribing Safety Info.

Also known as: ILARIS